The FDA has granted an Emergency Use Authorization (EUA) to VitalConnect that allows its VitalPatch wearable sensor to further monitor patients undergoing COVID-19 treatment.
As per the agency's letter of authorization, providers may use the remote-monitoring device in a hospital setting to spot changes in patients' QT interval, which may be dangerously prolonged by experimental drug treatments...
VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients undergoing treatment. Specifically, the study — which is funded by Johnson & Johnson subsidiary Janssen Pharmaceuticals — is looking to see how the technology can detect adverse events in cancer...
Data from a team of Dutch researchers presented this weekend at the Endocrinology Society’s annual meeting in Chicago demonstrated how vital monitoring wearables could identify Type 1 diabetes patients’ hypoglycemic events by measuring heart rate.
The pilot study outfitted 27 adult patients with VitalConnect’s HealthPatch MD, a continuous health monitor that the company has since replaced with...
Since July 2016, Apple has been in discussions with the FDA about two FDA-regulated products in the cardiac monitoring space, MobiHealthNews has learned. The revelation comes from a collection of emails MobiHealthNews obtained via a Freedom of Information Act request to the FDA.
On July 14, 2016, Robin Goldstein, at the time Principal Counsel for Apple, sent an email to FDA Associate Center...
EHR vendor Cerner has tapped telehealth provider American Well to deliver its virtual health care offerings. Through the partnership, American Well’s platform will integrate with Cerner’s EHR and be made available to all current and future Cerner and American Well clients. Patients will access the virtual care offering through Cerner’s HealtheLife patient engagement portal, which also provides...
Vital Connect, a Silicon Valley-based remote patient monitoring company, has raised $10.6 million according to an SEC filing. The funding, from undisclosed investors, continues a round begun way back in April 2013, and brings the total funding for the round to $18 million out of a planned $20 million. A spokesperson for the company told MobiHealthNews that an official funding announcement is...
Research firm Tractica predicts that worldwide unit shipments of clinical and non-clinical connected wearable patches will grow to 12.3 million per year by 2020. Last year, annual shipments were just 67,000. The market for such connected patches, Tractica predicts, will hit $3.3 billion per year.
Tractica describes the category as including "patches, tattoos, or small devices that are affixed to...
Vital Connect's HealthPatch, which partnered with LifeWatch last month
Swiss remote cardiac monitoring company LifeWatch has received FDA 510(k) clearance for LifeWatch VSP (Vital Signs Patch), the company's adhesive patch for remote patient monitoring.
"Being small in size, easy to affix, comfortable to wear and far less restrictive and cumbersome than numerous wired devices currently used,...
Pharmaceutical company GlaxoSmithKline is using mobile health tools in a small study -- just six subjects -- that could lead to there more widespread use in clinical trials. The company is working with data startup Medidata and sensor makers Vital Connect and ActiGraph to evaluate the impact of wearable sensors in clinical trial settings.
“Working with GSK on this initiative has provided us with...
Philips has unveiled a prototype system, consisting of a wearable sensor and connected software suite, to monitor patients with chronic obstructive pulmonary disease, or COPD. Philips worked with Radboud University Medical Center in the Netherlands to develop the system.
The sensor used to demo the prototype was the FDA-cleared HealthPatch sensor from Vital Connect, a peel and stick device that...
